Evidence map›Paper›PMID 12032333›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2002

A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.

Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, Michael H Tomasson, Ema Anastasiadou, Kathleen Lindahl, Shaoguang Li, Richard A Van Etten, Julian Borrow, David Housman and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 210 citations in OpenAlex.

  1. Article
  2. Identification of aeLife · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ajeeta B DashDivision of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Ifor R Williams
Jeffery L Kutok
Michael H Tomasson
Ema Anastasiadou
Kathleen Lindahl
Shaoguang Li
Richard A Van Etten
Julian Borrow
David Housman
Brian Druker
D Gary Gilliland
Howard Hughes Medical Institute · USMassachusetts Institute of Technology · USHarvard University · USOregon Health & Science University · US

Funding

TYROSINE KINASE ONCOGENESIS IN MYELOID LEUKEMIAP01CA066996 · NCI · DANA-FARBER CANCER INSTITUTE · PI JEROME RITZ · 1996 to 2026
$52.5M
SIGNAL TRANSDUCTION PATHWAYS IN STABLE PHASE CHRONIC MYELOID LEUKEMIA CELLSP01DK050654 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI D'ANDREA, ALAN DAVID · 1996 to 2006
$10.3M
ANTIGEN PRESENTATION AND COSTIMULATION BY KERATINOCYTESR29AR044268 · NIAMS · EMORY UNIVERSITY · PI WILLIAMS, IFOR R · 1996 to 2000
$108k
NCI NIH HHS CA66996NCI NIH HHS P01 CA066996NIAMS NIH HHS AR44268NIDDK NIH HHS DK50654NIDDK NIH HHS P01 DK050654
6 · The paper itself

Abstract

Constitutive activation of tyrosine kinases, such as the BCR/ABL fusion associated with t(9;22)(q34;q22), is a hallmark of chronic myeloid leukemia (CML) syndromes in humans. Expression of BCR/ABL is both necessary and sufficient to cause a chronic myeloproliferative syndrome in murine bone marrow transplantation models, and absolutely depends on kinase activity. Progression of CML to acute leukemia (blast crisis) in humans has been associated with acquisition of secondary chromosomal translocations, including the t(7;11)(p15;p15) resulting in the NUP98/HOXA9 fusion protein. We demonstrate that BCR/ABL cooperates with NUP98/HOXA9 to cause blast crisis in a murine model. The phenotype depends both on expression of BCR/ABL and NUP98/HOXA9, but tumors retain sensitivity to the ABL inhibitor STI571 in vitro and in vivo. This paradigm is applicable to other constitutively activated tyrosine kinases such as TEL/PDGFbetaR. These experiments document cooperative effects between constitutively activated tyrosine kinases, which confer proliferative and survival properties to hematopoietic cells, with mutations that impair differentiation, such as the NUP98/HOXA9, giving rise to the acute myeloid leukemia (AML) phenotype. Furthermore, these data indicate that despite acquisition of additional mutations, CML blast crisis cells retain their dependence on BCR/ABL for proliferation and survival.

Indexed as

AnimalsAntineoplastic AgentsBenzamidesBlast CrisisBone Marrow CellsBone Marrow TransplantationCell DivisionCloning, MolecularDisease Models, AnimalDisease ProgressionFusion Proteins, bcr-ablGreen Fluorescent ProteinsHomeodomain ProteinsHumansImatinib MesylateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntineoplastic AgentsBenzamidesFusion Proteins, bcr-ablGreen Fluorescent ProteinsHomeodomain ProteinsImatinib MesylateLuminescent ProteinsNuclear Pore Complex ProteinsNUP98-HOXA9 fusion protein, humanOncogene Proteins, FusionPiperazinesPyrimidines

Identifiers

PMID12032333
PMCPMC124303
OpenAlexW1992314522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.